Advances in the Treatment of Cognitive Impairment in Diseased Brain

The Collection "Advances in the Treatment of Cognitive Impairment in Diseased Brain" aims to explore the latest advancements and innovative approaches in addressing cognitive impairment associated with various diseases. Cognitive impairment is a common symptom observed in conditions such as Alzheimer's disease, Parkinson's disease, stroke, traumatic brain injury, and many others. This Collection seeks to provide a comprehensive overview of the emerging treatments and interventions designed to improve cognitive function in individuals affected by these diseases.

We would like to invite researchers, clinicians, and experts in the field to contribute original research articles, reviews, and case studies that focus on novel therapeutic strategies and interventions targeting cognitive impairment. Topics of interest include but are not limited to:

1) Pharmacological interventions: investigating the efficacy and safety of drugs targeting cognitive impairment in diseased brains.

2) Non-pharmacological interventions: exploring non-drug-based approaches such as cognitive training, neurorehabilitation techniques, and lifestyle modifications.

3) Neurostimulation techniques: examining the potential of brain stimulation methods like transcranial magnetic stimulation (TMS) and deep brain stimulation (DBS) in improving cognitive function.

4) Biomarkers and diagnostic tools: identifying reliable biomarkers and diagnostic tools for early detection and monitoring of cognitive impairment.

5) Personalized medicine: investigating individualized treatment approaches based on genetic, epigenetic, or other personalized factors.

6) Emerging technologies: exploring the role of emerging technologies like artificial intelligence, virtual reality, and wearable devices in cognitive rehabilitation.

Keywords: cognitive impairment, pharmacological interventions, non-pharmacological interventions, neurostimulation techniques, biomarkers, diagnosis